primary glomerular disease

ORPHA: 1023731 Treatment Available

Overview

human disease

Available Treatments (1)

DrugFormStatusCountriesLead Time
mycophenolate mofetil
oral capsule 250 mg, oral tablet 500 mg, IV infusion 500 mg/vial, oral suspension 200 mg/mLFDA Approved, EMA Approved113d

Classification & Codes

Orphanet Code

ORPHA:102373
primary glomerular disease
OrphanetORPHA:102373
Treatments1 drug(s)
Statuspublished

Treatment Summary

Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO